Getting Smarter in How We Score and Promote Value
May
Getting On Pathway?
Signaling the Future of Personalized Medicine
Money Well Spent?
SABCS Conference Coverage
This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.
Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy
Availability of Newer Agents May Lower Healthcare Costs
Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology
UPMC Oncologists: Pioneers in the Clinical Pathways Movement
Advertisement
Advertisement
Trending on AJMC
1
New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment
2
Team-Based Telehealth Model Matches In-Person Care for Atopic Dermatitis
3
JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain
4
AI Chatbots Score Below 28% on Colorectal Cancer Questions
5